Riverhead Capital

石晟昊, the firm's managing partner, is the named investment lead and public face of Riverhead Capital. He was recognized on the 投中 '2024 Top 20 China Healthcare Investors' list in January 2025 (per the firm). The firm has not disclosed a broader investment committee structure or additional partners.

Riverhead operates a dual-mandate platform. One arm pursues equity investments in healthcare, AI, consumer, and logistics technology companies — including positions in 迈瑞医疗, 商汤科技, and 满帮集团 — while a separate real estate arm, 融汇不动产基金, executes value-add office and hospitality conversions in Beijing, Shanghai, and Guangzhou. This hybrid structure is uncommon among domestic Chinese private equity managers, most of whom specialize in a single asset class.

Riverhead's disclosed portfolio spans the full company lifecycle, from RNA-interference drug developer 圣诺制药 to publicly listed medical-device manufacturers 迈瑞医疗 and 鱼跃医疗. The firm also backs mid-stage AI companies like 燧原科技 and 青云科技, reflecting a flexible mandate that covers early-stage venture through listed equities.

Riverhead's public materials emphasize direct equity and real estate positions; disclosed holdings are all direct company stakes or real property projects. No fund-of-funds activity or LP commitments to external managers have been disclosed, though information on the firm's strategy and vehicle structure remains limited.

The real estate franchise, branded as 融汇不动产基金, acquires underperforming urban properties and repositions them through renovation and active leasing. Active projects include a Shanghai Bund boutique hotel conversion, a Jing'an creative-office repositioning, and urban-renewal interventions in Guangzhou's Panyu and Tianhe districts — all suggesting a hold-and-operate rather than a pure trading model.

Riverhead has not published an explicit exclusion list. Based on its disclosed portfolio, the firm is absent from traditional heavy industry, upstream energy, and conventional financial services. Its concentration in healthcare, AI, logistics, consumer, and real estate suggests a deliberate focus on domestically-oriented, technology-enabled sectors.

Riverhead has not publicly described its co-investment practices. Its website lists only direct portfolio companies and proprietary real estate projects, with no mention of co-investor relationships or syndicate participation. In the absence of disclosure, its posture is assumed to be principal-only.